📊 FMCQF Key Takeaways
Is Fresenius Medical Care AG (FMCQF) a Good Investment?
Unable to conduct meaningful fundamental analysis due to unavailable financial data. The company's financial statements, balance sheet, cash flow, and profitability metrics are all missing from the provided SEC EDGAR data.
Fresenius Medical Care’s fundamentals improved meaningfully in 2025, with revenue rising to €19.6 billion, operating income up 31% to €1.8 billion, and net income attributable to shareholders up 82% to €978 million, while operating cash flow remained strong at €2.7 billion. Margin expansion, better cash collections, and solid liquidity support financial stability, but growth remains modest and the business still carries material debt and reimbursement/regulatory exposure. Returns are improving, yet ROIC at 5.0% remains below the company’s 7.0% WACC, which limits the case for a more aggressive rating based on fundamentals alone.
Why Buy Fresenius Medical Care AG Stock? FMCQF Key Strengths
- Company operates in established healthcare services sector (dialysis/renal care)
- Profitability improved sharply in 2025, with operating margin expanding to 9.3% from 7.2% and net income attributable to shareholders rising 82%
- Cash generation remains healthy, with €2.7 billion of operating cash flow and €1.8 billion of free cash flow in 2025
- Balance sheet remains serviceable, supported by €1.6 billion of cash and about €3.3 billion of available credit capacity
FMCQF Stock Risks: Fresenius Medical Care AG Investment Risks
- Complete absence of financial data prevents assessment of profitability
- Cannot evaluate financial health, leverage, or liquidity position
- No cash flow visibility to assess capital allocation and sustainability
- Insufficient insider activity data to gauge management confidence
- The company remains meaningfully leveraged, with consolidated debt of about €10.8 billion at year-end 2025
- Growth quality is only moderate because revenue increased just 2% reported and was partly offset by clinic divestitures and lower dialysis days
- A large share of revenue depends on government and insurer reimbursement, creating ongoing regulatory and pricing risk
Key Metrics to Watch
- Revenue and revenue growth trends
- Operating margins and net margins
- Free cash flow generation and conversion
- Debt levels and interest coverage ratios
- Operating margin and ROIC progression versus cost of capital
- Net leverage/debt reduction alongside free cash flow conversion
Fresenius Medical Care AG (FMCQF) Financial Metrics & Key Ratios
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
FMCQF Profit Margin, ROE & Profitability Analysis
FMCQF vs Services Sector: How Fresenius Medical Care AG Compares
How Fresenius Medical Care AG compares to Services sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Fresenius Medical Care AG Stock Overvalued? FMCQF Valuation Analysis 2026
Based on fundamental analysis, Fresenius Medical Care AG has mixed fundamental signals relative to the Services sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Fresenius Medical Care AG Balance Sheet: FMCQF Debt, Cash & Liquidity
FMCQF Revenue Growth, EPS Growth & YoY Performance
FMCQF SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Fresenius Medical Care AG (CIK: 0001333141)
📋 Recent SEC Filings
❓ Frequently Asked Questions about FMCQF
What is the AI rating for FMCQF?
Fresenius Medical Care AG (FMCQF) has a Combined AI Rating of HOLD from Claude (HOLD) and ChatGPT (HOLD) with 41% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are FMCQF's key strengths?
Claude: Company operates in established healthcare services sector (dialysis/renal care). ChatGPT: Profitability improved sharply in 2025, with operating margin expanding to 9.3% from 7.2% and net income attributable to shareholders rising 82%. Cash generation remains healthy, with €2.7 billion of operating cash flow and €1.8 billion of free cash flow in 2025.
What are the risks of investing in FMCQF?
Claude: Complete absence of financial data prevents assessment of profitability. Cannot evaluate financial health, leverage, or liquidity position. ChatGPT: The company remains meaningfully leveraged, with consolidated debt of about €10.8 billion at year-end 2025. Growth quality is only moderate because revenue increased just 2% reported and was partly offset by clinic divestitures and lower dialysis days.
What is FMCQF's revenue and growth?
Fresenius Medical Care AG reported revenue of N/A.
Does FMCQF pay dividends?
Fresenius Medical Care AG does not currently pay dividends.
Where can I find FMCQF SEC filings?
Official SEC filings for Fresenius Medical Care AG (CIK: 0001333141) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is FMCQF's EPS?
Fresenius Medical Care AG has a diluted EPS of $0.00.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is FMCQF a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, Fresenius Medical Care AG has a HOLD rating with 41% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is FMCQF stock overvalued or undervalued?
Valuation metrics for FMCQF: ROE of N/A (sector avg: 16%), net margin of N/A (sector avg: 10%). Compare these metrics with sector averages to assess valuation.
Should I buy FMCQF stock in 2026?
Our dual AI analysis gives Fresenius Medical Care AG a combined HOLD rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is FMCQF's free cash flow?
Fresenius Medical Care AG's operating cash flow is N/A, with capital expenditures of N/A.
How does FMCQF compare to other Services stocks?
Vs Services sector averages: Net margin N/A (avg: 10%), ROE N/A (avg: 16%), current ratio N/A (avg: 1.5).